| Recurrent readmissions in medical patients: a prospective study AM Mudge, K Kasper, A Clair, H Redfern, JJ Bell, MA Barras, G Dip, ... Journal of Hospital Medicine 6 (2), 61-67, 2011 | 200 | 2011 |
| Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and … JH Martin, R Norris, M Barras, J Roberts, R Morris, M Doogue, GRD Jones The Clinical biochemist Reviews 31 (1), 21, 2010 | 189 | 2010 |
| The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’ J Lindsay, M Dooley, J Martin, M Fay, A Kearney, M Khatun, M Barras Supportive care in cancer 23, 71-78, 2015 | 162 | 2015 |
| Endothelial function and dysfunction: Impact of metformin A Nafisa, SG Gray, Y Cao, T Wang, S Xu, FH Wattoo, M Barras, N Cohen, ... Pharmacology & therapeutics 192, 150-162, 2018 | 111 | 2018 |
| Drug dosing in obese adults M Barras, A Legg Australian prescriber 40 (5), 189, 2017 | 105 | 2017 |
| Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review IA Scott, PI Pillans, M Barras, C Morris Therapeutic advances in drug safety 9 (9), 559-573, 2018 | 92 | 2018 |
| Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches J Lindsay, M Dooley, J Martin, M Fay, A Kearney, M Barras Supportive Care in Cancer 22, 1113-1119, 2014 | 87 | 2014 |
| New oral anticoagulants: appropriateness of prescribing in real‐world setting CS Pattullo, M Barras, B Tai, M McKean, P Donovan Internal Medicine Journal 46 (7), 812-818, 2016 | 74 | 2016 |
| Systematic review of predictive risk models for adverse drug events in hospitalized patients N Falconer, M Barras, N Cottrell British journal of clinical pharmacology 84 (5), 846-864, 2018 | 64 | 2018 |
| Defining and classifying terminology for medication harm: a call for consensus N Falconer, M Barras, J Martin, N Cottrell European journal of clinical pharmacology 75, 137-145, 2019 | 60 | 2019 |
| Individualized compared with conventional dosing of enoxaparin MA Barras, SB Duffull, JJ Atherton, B Green Clinical Pharmacology & Therapeutics 83 (6), 882-888, 2008 | 50 | 2008 |
| Individualised medicine: why we need Bayesian dosing J Donagher, JH Martin, MA Barras Internal Medicine Journal 47 (5), 593-600, 2017 | 49 | 2017 |
| Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing A Mudge, K Radnedge, K Kasper, R Mullins, J Adsett, S Rofail, S Lloyd, ... Australian Health Review 40 (1), 86-91, 2015 | 48 | 2015 |
| Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development RL Norris, JH Martin, E Thompson, JE Ray, RO Fullinfaw, D Joyce, ... Therapeutic drug monitoring 32 (5), 615-623, 2010 | 47 | 2010 |
| Investigating strategies used by hospital pharmacists to effectively communicate with patients during medication counselling BAM Chevalier, BM Watson, MA Barras, WN Cottrell Health Expectations 20 (5), 1121-1132, 2017 | 40 | 2017 |
| Bayesian estimation of tobramycin exposure in patients with cystic fibrosis MA Barras, D Serisier, S Hennig, K Jess, RLG Norris Antimicrobial agents and chemotherapy 60 (11), 6698-6702, 2016 | 35 | 2016 |
| Reporting a population pharmacokinetic–pharmacodynamic study: A journal’s perspective KM Jamsen, SC McLeay, MA Barras, B Green Clinical pharmacokinetics 53, 111-122, 2014 | 34 | 2014 |
| Current dosing of low‐molecular‐weight heparins does not reflect licensed product labels: an international survey MA Barras, CMJ Kirkpatrick, B Green British journal of clinical pharmacology 69 (5), 520-528, 2010 | 30 | 2010 |
| Hospital pharmacists' perceptions of medication counseling: A focus group study BAM Chevalier, BM Watson, MA Barras, WN Cottrell Research in Social and Administrative Pharmacy 12 (5), 756-771, 2016 | 27 | 2016 |
| Monitoring of tobramycin exposure: what is the best estimation method and sampling time for clinical practice? Y Gao, S Hennig, M Barras Clinical pharmacokinetics 58, 389-399, 2019 | 25 | 2019 |
